Browsing Tag
Vaxcyte
5 posts
Vaxcyte’s $1bn Thermo Fisher deal: Can new U.S. vaccine capacity secure its PCV future?
Vaxcyte partners with Thermo Fisher in a $1B deal to build U.S. fill-finish vaccine capacity. Find out why this matters for its PCV pipeline and investors.
September 30, 2025
Sarepta, Palantir, Moderna lead Wall Street declines as biotech, tech stocks tumble
U.S. stock market losers on May 6, 2025: Find out why Sarepta, Palantir, Moderna, Lattice Semiconductor and more saw sharp stock price drops.
May 7, 2025
Wall Street turmoil: These 25 stocks plunged hardest amid Trump tariffs and sector shocks
Allegro MicroSystems, MP Materials, ZEEKR, and Albertsons led losses on April 15, 2025, as trade tensions, sector headwinds, and investor caution triggered a widespread selloff across US markets.
April 16, 2025
US stock market declines as Vaxcyte, Biohaven, and Moderna lead losses
US stocks closed sharply lower on March 31, 2025, led by biotech and tech losses. Learn why markets are reacting to tariffs, interest rates, and economic uncertainty.
April 1, 2025
Vaxcyte gets FDA fast track designation for PCV candidate VAX-24
Vaxcyte has secured fast track designation for VAX-24, its 24-valent pneumococcal conjugate vaccine (PCV) candidate, from the US…
August 7, 2022